About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5514353
Allelic
Composition
Fktntm3.1Ttd/Fktntm3.1Ttd
Myf5tm3(cre)Sor/Myf5+
Genetic
Background
involves: 129S4/SvJaeSor * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fktntm3.1Ttd mutation (0 available); any Fktn mutation (44 available)
Myf5tm3(cre)Sor mutation (1 available); any Myf5 mutation (17 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• most mice die by 6 months

muscle
• adult mice exhibit fewer muscle progenitor cells compared with control mice
• however, infection with an Fktn-expressing adenovirus rescues collagen accumulation
• at 4, 8 and 16 weeks
• however, infection with an Fktn-expressing adenovirus rescues nucleus localization
• however, infection with an Fktn-expressing adenovirus rescues muscle weight
• severe in some mice treated with cardiotoxin
• at 16 weeks, but not in young mice
• at 16 weeks
• at 4, 8 and 16 weeks
• adult mice exhibit impaired muscle progenitor cell viability compared with control mice
• after cardiotoxin treatment, mice exhibit reduced regenerative capacity in TA muscles with increased smaller regenerating fibers compared with control mice
• however, infection with an Fktn-expressing adenovirus rescues regeneration

growth/size/body
• however, infection with an Fktn-expressing adenovirus rescues body weight
• after 2 weeks of age

homeostasis/metabolism

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
muscular dystrophy-dystroglycanopathy type B1 DOID:0050588 OMIM:613155
J:198535


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory